Rheumatoid arthritis. Rheumatoid arthritis with rheumatoid factor
Conditions
Interventions
Intervention 1: Intervention group 1:The first group is group A, in this group, the extract of the native plant of Iran, koma (Freula persica), which is obtained from its root and stem, and the hydroa
Sponsors
Islamic Azad University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients Suffering from Joint Pain and Rheumatoid arthritis Age 18 to 80 Years Old Body Weight 60 to 150 kg Gender Male & Female Daily Activity Rate from 0 to 24 Hours
Exclusion criteria
Exclusion criteria: Pregnant and Nursing mothers Taking Confounding Medications such as Corticosteroids and NSAIDs Confounding Surgical Records Based on Orthopedic, Brain, or any Type of Surgery That Disrupts the Immune and Motor Systems. Suffering from diseases of the immune and motor systems except Rheumatoid arthritis Confounding Occupations Based on the Place, Manner and Hours of Activity That are Effective on The Improvement or Non-Improvement of the Disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of Rheumatoid factor in Patient Tests after Drug Administration. Timepoint: At the Beginning of the Study, before the Start of the Intervention and then after the end of the Intervention (after 4 Months). Method of measurement: Rheumatoid factor Test by Blood sampling.;Reduction of Antibodies Against cyclic citrullinated peptides (Anti-CCP Antibodies). Timepoint: At the Beginning of the Study, before the Start of the Intervention and then after the end of the Intervention (after 4 Months). Method of measurement: Anti cyclic citrullinated peptide(Anti-CCP)Test by Blood sampling.;Pain reduction. Timepoint: At the Beginning of the Study (before the start of the Intervention) and once a Week until the end of the Intervention and Completion of the Treatment. Method of measurement: Clinical examinations; ?Questionnaires.;Inflammation reduction. Timepoint: At the Beginning of the Study (before the start of the Intervention) and once a Month until the end of the Intervention and Completion of the Treatment. Method of measurement: Clinical examinations; C-reactive protein measurement by blood sampling (CRP). | — |
Secondary
| Measure | Time frame |
|---|---|
| Effective on other Joint pains. Timepoint: At the Beginning of the Study (before the start of the Intervention) and once a Week until the end of the Intervention and Completion of the Treatment. Method of measurement: Clinical examinations; Questionnaires. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactArmin Deyhim
Islamic Azad University
Outcome results
None listed